Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...

Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

"What's so beautiful about not helping people?" asked one participant in the Veteran's Alcoholic Rehabilitation Program. "Why ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

Trump has a penchant for inventing numbers to oversell his economic policies. He previously claimed that he’d already struck ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

OPM is on track to cut one-third of its staff by Dec. 31, largely through voluntary departures, from 3,110 employees to ...